OVERKILL Frontman Interviewed On 'Metal Crypt'; Audio Available
February 17, 2010Vocalist Bobby "Blitz" Ellsworth of veteran New Jersey thrashers OVERKILL was interviewed on the February 10 edition of the "Metal Crypt" show on Hard Rock Radio Live. You can now listen to the chat in two parts below.
OVERKILL's new album, "Ironbound", sold 4,100 copies in the United States in its first week of release to debut at position No. 192 on The Billboard 200 chart. The CD landed at No. 4 on the Top New Artist Albums (Heatseekers) chart, which lists the best-selling albums by new and developing artists, defined as those who have never appeared in the Top 100 of The Billboard 200.
OVERKILL's previous album, "Immortalis", opened with 2,800 units back in October 2007 .
OVERKILL's top-selling album of the SoundScan era (1991-) is "Horrorscope", which has shifted more than 120,000 copies in the U.S. since its 1991 release (there is no SoundScan data available for LPs sold prior to 1991).
"Ironbound" was released on February 9 via E1 Music (formerly KOCH Records). The CD, which was issued in Europe on January 29 via Nuclear Blast Records, was mixed by PAIN/HYPOCRISY mainman Peter Tägtgren and is described in a press release as "a true thrasher-piece."
OVERKILL kicked off its European tour on February 6 at De Pul in Uden, The Netherlands. Support at the gig came from SUICIDAL ANGELS, SAVAGE MESSIAH and CRIPPER.
A number of high-quality photos from the show can be found at Metal-Experience.com.
OVERKILL filmed a video for the song "Bring Me The Night" on January 9 in Brooklyn, New York with director Kevin Custer (HATEBREED, TESTAMENT, SUFFOCATION). The clip can now be viewed below.
OVERKILL will embark on its 25th anniversary North American tour, dubbed Killfest 2010, in April/May 2010. The trek will span the length of the U.S., hitting spots in Canada, with one final show at New York City's Nokia Theater. Support on the tour will come from VADER, GOD DETHRONED, WARBRINGER, EVILE and WOE OF TYRANTS.
Interview Part 1:
Interview Part 2:
Comments Disclaimer And Information